Abstract

Liver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by Schistosoma japonicum (S. japonicum) infection or Carbon tetrachloride (CCl4) intraperitoneal injection is a conventional model used in liver fibrosis-related studies for mechanism or pharmaceutical research purposes. But the differences in the pathological progression, immune responses and the underlying mechanism between the two liver fibrosis model have not been carefully compared and characterized, which hinders us from correctly understanding and making better use of the two models. In the present study, the pathological changes to the liver, and the cytokines, inflammatory factors, macrophages, and lymphocytes subsets involved were analyzed in the liver fibrosis model of S. japonicum infection or CCl4 intraperitoneal injection. Additionally, the pathological progression, immune responses and the underlying injury mechanism in these two models were compared and characterized. The results showed that the changing trend of interleukin-13 (IL-13), transforming growth factor beta (TGF-β), inflammatory factors, and M1, M2 macrophages, were consistent with the development trend of fibrosis regardless of whether liver fibrosis was caused by S. japonicum or CCl4. For lymphocyte subsets, the proportions of CD3+ T cells and CD4+ T cells decreased gradually, while proportion of CD8+ T cells peaked at 6 weeks in mice infected with S. japonicum and at 12 weeks in mice injected with CCl4. With prolonged S. japonicum infection time, Th1 (CD4+IFN-γ+) immunity converted to Th2 (CD4+IL-4+)/Th17 (CD4+IL-17+) with weaker regulatory T cell (Treg) (CD4+CD25+FOXP3+) immunity. However, in liver fibrosis caused by CCl4, Th1 cells occupied the dominant position, while proportions of Th2, Th17, and Treg cells decreased gradually. In conclusion, liver fibrosis was a complex pathological process that was regulated by a series of cytokines and immune cells. The pathological progressions and immune responses to S. japonicum or CCl4 induced liver fibrosis were different, possibly because of their different injury mechanisms. The appropriate animal model should be selected according to the needs of different experiments and the pathogenic factors of liver fibrosis in the study.

Highlights

  • Liver fibrosis caused by, for example, metabolic diseases, virus infection, and drug toxicity, result in liver injury and inflammation

  • The liver surface of mice infected with S. japonicum had obvious egg nodules, and diffuse granular nodules on the liver surface of mice injected with CCl4 were seen (Figure 1E)

  • The level of ALT in mice infected with S. japonicum at 6 weeks was higher than that of mice injected with CCl4

Read more

Summary

Introduction

For example, metabolic diseases, virus infection, and drug toxicity, result in liver injury and inflammation. These factors stimulate the quiescent hepatic stellate cells (HSCs), which are activated and differentiate into myofibroblasts, secreting a large amount of extracellular matrix (ECM) components, such as collagen, glycoprotein, and proteoglycan. Myofibroblast tissue metalloproteinase inhibitors (TIMPs) secreted by cells inhibit the activity of matrix metalloproteinases (MMPs) in degrading the ECM, resulting in abnormal deposition of fibrous connective tissue in the liver and the formation of liver fibrosis [1, 2]. It is very important to study the pathological characteristics and possible regulatory mechanisms of liver fibrosis to search for novel treatments

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call